Trial Profile
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Feb 2024
Price :
$35
*
At a glance
- Drugs Glucarpidase (Primary) ; Folinic acid; Methotrexate; Rituximab
- Indications B-cell lymphoma; Chemotherapy-induced damage; CNS cancer; Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- 19 Feb 2024 Planned End Date changed from 1 Nov 2024 to 1 Nov 2025.
- 19 Feb 2024 Planned primary completion date changed from 1 Nov 2024 to 1 Nov 2025.
- 11 Jul 2022 Planned End Date changed from 1 Oct 2024 to 1 Nov 2024.